301 CARLSON PARKWAY, MINNEAPOLIS, MN
Voting Results from Diamedica Therapeutics Inc. Shareholder Meeting
Reports First Quarter 2026 Financial Results and Provides Business Highlights
Annual Report to Security Holders
Financial Results, Press Release
Other Events
Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus Filed Pursuant to Rule 424(b)(2)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload